MacroGenics
MGNX
#8794
Rank
A$0.34 B
Marketcap
A$5.35
Share price
5.35%
Change (1 day)
98.01%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: A$0.34 Billion

As of October 2026 MacroGenics has a market cap of A$0.34 Billion. This makes MacroGenics the world's 8794th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.34 B124.22%
2025A$0.15 B-53.35%
2024A$0.32 B-62.79%
2023A$0.87 B44.49%
2022A$0.60 B-55.34%
2021A$1.35 B-18.83%
2020A$1.67 B

End of Day market cap according to different sources

On Oct 9th, 2026 the market cap of MacroGenics was reported to be:

A$0.34 Billion
by Nasdaq info icon info icon
A$0.34 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$230.67 B 67,557.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.504 T 441,117.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$320.98 B 94,045.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$268.25 B 78,579.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$514.08 B 150,681.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$172.82 B 50,590.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$2.62 B 668.69%๐Ÿ‡บ๐Ÿ‡ธ USA